Design, synthesis and biological evaluation of bitopic arylpiperazine-hexahydro-pyrazinoquinolines as preferential dopamine D3 receptor ligands

Add time:08/21/2019    Source:sciencedirect.com

Three series of bitobic arylpiperazine-phenyl-hexahydropyrazinoquino- lines analogues were designed, synthesizedand evaluated as a novel class of selective ligands for the dopamine D3 receptor. Compounds 15a (Ki of 11.7 ± 1.8 and 373 nM at D3 and D2, respectively), 15c (Ki of 5.49 and 264 nM at D3 and D2, respectively), 15e (Ki of 14.9 and 325 nM at D3 and D2, respectively), 15i (Ki of 13.8 and 401 nM at D3 and D2, respectively) and 15l (Ki of 13.6 and 870 nM at D3 and D2, respectively) were found to demonstrate good binding affinity and selectivity, and especially compound 15c showeda similar binding affinity and selectivity compared with the contrast drug BP897.

We also recommend Trading Suppliers and Manufacturers of 2,3,4,4a,5,6-Hexahydro-7-methoxyquinoline (cas 19500-64-2). Pls Click Website Link as below: cas 19500-64-2 suppliers

Prev:Research paperAntileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents
Next:Oxidation of Shenmu char powder with aqueous hydrogen peroxide–acetic anhydride)